This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Sep. 4, 2012


Increased role of pharmacists — safer medication use
University of Queensland via Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at the University of Queensland's School of Pharmacy in Australia are making medication use safer by incorporating pharmacists into general practice medical centers. The study, led by Christopher Freeman, a registered pharmacist currently completing his Ph.D. with the School of Pharmacy at the University of Queensland, showed that general practitioner referrals for medication reviews at the clinic increased by more than 400 percent during the period of the study. More

 Area and Association News

Team Up. Pressure Down. Coaching Patients to Take Control.
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Citing strong evidence of effectiveness, the U.S. Preventive Services Task Force in May 2012 recommended team‐based care — uniting the efforts of physicians, pharmacists, nurses and other health care professionals — to improve blood pressure control. Join the launch and/or one of four live CPE webinars (starting on September 5th) to learn more about Team Up. Pressure Down., a new Million Hearts™ educational program that offers support and resources for health care professionals working to help Americans improve medication adherence and more effectively manage their blood pressure. To register for the launch webinar, visit To learn more about the free CPE webinar and to register, visit under "Of Interest."

CDC Treatment Recommendations for Gonorrhea
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Due to concerns regarding emerging gonococcal resistance to cephalosporins, CDC updated the 2010 STD Treatment Guidelines on August 9, 2012 for gonorrhea treatment through release of the Morbidity and Mortality Weekly Report, Vol. 61/No. 31 ( The Arizona STD Control Program strongly recommends that all Arizona health care providers utilize the revised CDC 2010 STD Treatment Guidelines for treatment of gonorrhea. Since April 2007, CDC has advised providers to discontinue the use of quinolones (ciprofloxacin, ofloxacin, and levofloxacin) for the treatment of gonorrhea, based on data indicating widespread drug resistance in the U.S. High levels of resistance to quinolones continue to be observed nationally and in Arizona. The revised gonorrhea treatment regimens are shown below and are also located at More

PTCB Exam Prep Course

AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
PTCB Exam Prep Course Begins September 8, 2012. Visit the Arizona Pharmacy Association website for complete information.

Community Pharmacy Academy Conference Changes Ahead
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Community Pharmacy Academy Conference Changes Ahead: Are You Ready?
September 22, 2012
Crowne Plaza Phoenix Airport Hotel

To register for the event, please click here.

 Pharmacy Updates

Meijer adds generic version of Lipitor to free prescription program
The Grand Rapids Press    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Meijer will begin offering the generic substitute for Lipitor for free in all its 199 pharmacies, the retailer recently announced. The addition expands the retailer's free medication program, and makes Meijer the first retailer in the Midwest to offer this generic cholesterol lowering medication free to customers with a physician's prescription. More

Kroger pharmacies, The Little Clinic now offering flu shots
Drug Store News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Kroger has announced that it is offering $25 flu shots at more than 1,900 Kroger pharmacy locations nationwide and at The Little Clinic locations inside select stores. Flu shots are available for ages 2 years and older and high-dose flu shots are available for patients ages 65 years and older. More

 In the News

Study: Doctors closing door on oncology drug repsclosing
The Philadelphia Inquirer    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Targeted cancer drugs are one of the great hopes for pharmaceutical companies, but a business survey says cancer doctors are limiting visits by sales representatives more than most medical specialists. ZS Associates, a global sales and marketing firm, published its spring 2012 AccessMonitor report and it says about 61 percent of oncologists placed moderate-to-severe restrictions on visits from pharmaceutical sales reps. More

NCPA endorses Pennsylvania pharmacy audit reform bill
Drug Store News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The National Community Pharmacists Association is encouraging Pennsylvania lawmakers to favorably move legislation — known as H.B.727 — that is designed to "establish minimum and uniform standards and criteria for the audit of pharmacy records." More

Hospital pharmacists must get creative amid drug shortages
Crain's Cleveland Business (free subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The medicine cabinets at northeast Ohio's hospitals are sparse these days, and while it's no fault of their own, a nationwide drug shortage has forced pharmacists to come up with creative ways to make supplies of medications last. Although the federal government has offered a few tools to ease the burden, local hospital pharmacists say the shortages show few signs of easing. More than 200 drugs are in short supply or unavailable entirely; the bulk of these are generic injectable drugs. Alternatives, if they exist, often are sold at high markups. More

 FDA News

New option for constipation: FDA approves linaclotide
Medscape News (free subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration approved the drug linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation in adults. "We have several therapies already available to us for chronic constipation that generally work well, whereas for IBS, it [is] a much different story," said Dr. Brennan Spiegel, associate professor of medicine at the Veterans Affairs Greater Los Angeles Healthcare System. "In that regard, it looks very promising, not just for constipation but abdominal bloating and pain and a lot of other features, and there aren't many other effective therapies." More

FDA backs use of Humira to treat ulcerative colitis
Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Abbott Laboratories Inc. won a U.S. panel's support for wider use of its blockbuster rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease. A panel of outside advisers to the Food and Drug Administration voted 15 to 2 that the benefits of Humira outweighed its risks in treating ulcerative colitis. The drug is already approved for six other conditions. More

Xtandi approved for advanced prostate cancer
HealthDay News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Xtandi has been approved to treat men with prostate cancer that has spread despite treatment with standard therapies aimed at minimizing the effects of testosterone. Xtandi, given priority FDA review, was evaluated in clinical studies of almost 1,200 men with metastatic, hormone treatment-resistant prostate cancer who had taken docetaxel previously. Average survival among those who took Xtandi was 18.4 months, compared with 13.6 months among those who took a placebo. More

FDA approves wider use for J&J Nucynta ER pain drug
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Johnson & Johnson unit Janssen Pharmaceuticals said it received U.S. regulatory approval for a wider use of its Nucynta ER painkiller, for pain from nerve damage brought on by diabetes. Nucynta ER, an opioid, is already approved for extended use in moderate to severe chronic pain. But the expanded approval from the Food and Drug Administration allows Janssen to market the drug for pain tied to diabetic peripheral neuropathy, which affects up to 8 million Americans. More


AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Content Editor, 469.420.2696   
Contribute news

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Sept. 4, 2012
Aug. 28, 2012
Aug. 21, 2012
Aug. 14, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063